Richard Green is a Gastroenterology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
259 E Erie St Fl 16
Chicago, IL 606112987
Telephone
312-695-5620Registry record last updated 17 Oct 2019.
Clinical trials
- Modified Story Memory Technique (mSMT) in Persons With TBI
Sponsor: Kessler Foundation
- Treating Cognitive Deficits in Traumatic Spinal Cord Injury (SCI)
Sponsor: Kessler Foundation
- CAPTURE 2 Post-Marketing Registry
Sponsor: Abbott Medical Devices
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mirum Pharmaceuticals, Inc.Program year202517 payments
- Mirum Pharmaceuticals, Inc.Program year202415 payments
- Mirum Pharmaceuticals, Inc.Program year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
42.5%Bile Acid42.5%Ursodiol100%Part D≥21 patientsAnti-infectives
33.3%Nucleoside and nucleotide reverse transcriptase inhibitors26.3%Vemlidy53%Tenofovir Disoproxil Fumarate47%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor7%Entecavir100%Part D<11 patientsCancer & immunology
24.2%Purine Antimetabolite24.2%Azathioprine100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
11 NIH research awards on record, funded 1990–2026 per NIH RePORTER. The latest:
- The Unfolded Protein Response and Bile Acid Metabolism
Northwestern University
FY2026$664,243R01DK138080 - The Unfolded Protein Response and Bile Acid Metabolism
Northwestern University
FY2025$625,813R01DK138080
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”